Canada Pure Nicotine Market Size & Outlook, 2026-2034

Canada Pure Nicotine Market Insights

As highlighted in Deep Market Insights analysis, the Canada Pure Nicotine Market, worth USD 59.2 Million in 2025, is forecasted to achieve USD 120.28 Million by 2034.
The Canada market is anticipated to grow at a CAGR of 8.2% during the period 2026–2034.
By 2025, Natural nicotine represented the largest share of the By Type market size.
Nicotine salts is expected to remain the key growth driver within By Type, registering the fastest CAGR during the forecast period.

In 2025, Canada accounted for 7.4% of the global Pure Nicotine Market size.
By 2034, United States is expected to lead the global Pure Nicotine Market in terms of market size.
Within North America, United States is projected to dominate the regional Pure Nicotine Market size by 2034.
Canada is identified as the fastest-growing market in North America, anticipated to reach USD 120.31 Million by 2034.

Report Scope	Details
Base Year for Study	2025
Study Period	2022-2034
Historical Period	2022-2024
Forecast Period	2026-2034
Market Size In 2025	USD 59.2 Million
Market Size In 2034	USD 120.28 Million
Largest segment	Natural nicotine
Units	Revenue in USD Million
CAGR	8.2% (2026-2034)
Segmnetation Covered
By Type	Natural nicotine Synthetic nicotine Liquid nicotine Nicotine salts
By Purity Level	Below 99% 99% purity Above 99% Pharmaceutical grade
By Application	E-liquids Pharmaceuticals Nicotine gums Research use
By End User	Tobacco companies Pharma companies Research institutes E-liquid manufacturers
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

By Type	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Natural nicotine	XX.x	XX.x	XX.x	28.93	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Synthetic nicotine	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Liquid nicotine	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Nicotine salts	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

By Purity Level	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Below 99%	XX.x	XX.x	XX.x	26.74	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
99% purity	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Above 99%	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Pharmaceutical grade	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

By Application	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
E-liquids	XX.x	XX.x	XX.x	29.03	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Pharmaceuticals	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Nicotine gums	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Research use	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

By End User	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Tobacco companies	XX.x	XX.x	XX.x	23.87	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Pharma companies	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Research institutes	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
E-liquid manufacturers	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x